Skip to content

Evaluation of the effectiveness of progressive muscle relaxation on maternal and neonatal outcomes on primary parous women with preeclampsia

Evaluation of the effectiveness of progressive muscle relaxation on maternal and neonatal outcomes on primiparous women with preeclampsia in Kamali hospital,Karaj, Iran 2019-2020

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180110038302N6
Enrollment
88
Registered
2020-06-27
Start date
2020-03-19
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia. Eclampsia in pregnancy, unspecified trimester

Interventions

Intervention 1: Intervention group: using progressive muscle relaxation, which is done for 12 sessions by 6 weeks and 2 sessions per week. Intervention 2: Control group:beside routine prenatal care,No

Sponsors

Alborz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: primary parous women with 26-34 weeks gestational age singleton pregnancy non-severe preeclampsia criterias low risk results in the frist and second trimester fetal screenings persiane race and at least having reading and writing literacy

Exclusion criteria

Exclusion criteria: physical and mental illnesses (such as cardio-respiratory disease, diabetes mellitus and gestational diabetes, seizure, depression, anxiety disorders ,etc) history of infertility and/or repeated miscarriage vaginal hemorrhage and/or leaking amniotic fluid and/or uterine contractions recent severe stress and/or anxiety intrauterine growth restriction usage of alcohol and/or cigarettes and/or drugs

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: before and after 6 weeks of intervention. Method of measurement: mercury sphygmo manometer.

Secondary

MeasureTime frame
Proteinuria. Timepoint: before and after 6 weeks of intervention. Method of measurement: collect a 24-hr clean midstream urine sample.;Fasting blood sugar. Timepoint: before and after 6 weeks of intervention. Method of measurement: glucometer.;Maternal weight gaining. Timepoint: before and after 6 weeks of intervention. Method of measurement: digital scale.;Turn to severe preeclampsia. Timepoint: after 6 weeks of intervention. Method of measurement: collect a 24-hr clean midstream urine sample and mercury sphygmo manometer.;Delivery gestational age. Timepoint: after 6 weeks of intervention. Method of measurement: hospital document.;Amniotic fluid index. Timepoint: before and after 6 weeks of intervention. Method of measurement: ultra sonogram.;Fetal movement. Timepoint: before and after 6 weeks of intervention. Method of measurement: none stress test.;Fetal heart rate. Timepoint: before and after 6 weeks of intervention. Method of measurement: none stress test.;Apgar score. Timepoint: after 6 weeks of intervention. Method of measurement: hospital document.;Antropometric index. Timepoint: after 6 weeks of intervention. Method of measurement: hospital document.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansooreh Yazdkhusti

Alborz medical science university

Mansoyazd@yahoo.com+98 26 3428 7483

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026